Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage

被引:151
作者
Wang, J [1 ]
Rogove, AD [1 ]
Tsirka, AE [1 ]
Tsirka, SE [1 ]
机构
[1] Univ Med Ctr Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA
关键词
D O I
10.1002/ana.10750
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Intracerebral hemorrhage (ICH) causes morbidity and mortality and commonly follows the reperfusion after an ischemic event. Tissue plasminogen activator (tPA), a fibrinolytic serine protease, is routinely given for the treatment of stroke. However, tPA also can promote neuronal death, suggesting that caution should be exercised when using it. Furthermore, tPA upon brain injury mediates microglial activation and modulates neuronal survival. To investigate the role of tPA and microglia during brain hemorrhage, we induced experimentally ICH by intracerebral injection of collagenase. Seven days after the introduction of ICH, it persisted in tPA-deficient (tPA(-/-)) mice but is drastically reduced in size in wild-type mice. Three weeks after ICH, there are still red blood cells in tPA(-/-) but not in wild-type animals. Activated microglia persist around the injury site. When microglial activation is inhibited by tuftsin fragment 1-3 macrophage/microglial inhibitory factor (MIF), the stroke injury volume is significantly reduced, and the neurobehavioral deficits exhibited by the mice are improved. Our results suggest that endogenous tPA assists in the clearance of intracerebral hemorrhage, presumably by affecting microglial activation, and MIF could be a valuable neuroprotective agent for the treatment of ICH.
引用
收藏
页码:655 / 664
页数:10
相关论文
共 24 条
[1]   CHARACTERIZATION AND SYNTHESIS OF A MACROPHAGE INHIBITORY PEPTIDE FROM THE 2ND CONSTANT DOMAIN OF HUMAN IMMUNOGLOBULIN-G [J].
AURIAULT, C ;
JOSEPH, M ;
TARTAR, A ;
CAPRON, A .
FEBS LETTERS, 1983, 153 (01) :11-15
[2]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[3]   Molecular signatures of brain injury after intracerebral hemorrhage [J].
Castillo, J ;
Dávalos, A ;
Alvarez-Sabín, J ;
Pumar, JM ;
Leira, R ;
Silva, Y ;
Montaner, J ;
Kase, CS .
NEUROLOGY, 2002, 58 (04) :624-629
[4]   Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice [J].
Choudhri, TF ;
Hoh, BL ;
Solomon, RA ;
Connolly, ES ;
Pinsky, DJ .
STROKE, 1997, 28 (11) :2296-2302
[5]   Citicoline treatment for experimental intracerebral hemorrhage in mice [J].
Clark, W ;
Gunion-Rinker, L ;
Lessov, N ;
Hazel, K .
STROKE, 1998, 29 (10) :2136-2139
[6]  
Clark WM, 1997, NEUROL RES, V19, P641
[7]   Acute inflammatory reaction following experimental intracerebral hemorrhage in rat [J].
Gong, C ;
Hoff, JT ;
Keep, RF .
BRAIN RESEARCH, 2000, 871 (01) :57-65
[8]   Intracerebral hemorrhage-induced neuronal death [J].
Gong, C ;
Boulis, N ;
Qian, J ;
Turner, DE ;
Hoff, JT ;
Keep, RF .
NEUROSURGERY, 2001, 48 (04) :875-882
[9]   Nuclear factor-κB and cell death after experimental intracerebral hemorrhage in rats [J].
Hickenbottom, SL ;
Grotta, JC ;
Strong, R ;
Denner, LA ;
Aronowski, J .
STROKE, 1999, 30 (11) :2472-2477
[10]   Vampire bat salivary plasminogen activator (desmoteplase) - A unique fibrinolytic enzyme that does not promote neurodegeneration [J].
Liberatore, GT ;
Samson, A ;
Bladin, C ;
Schleuning, WD ;
Medcalf, RL .
STROKE, 2003, 34 (02) :537-543